joseph r. moskal, Ph.D.
Affiliations: | Biomedical Engineering | Northwestern University, Evanston, IL |
Area:
Pharmacogenomics, Drug Discovery, Brain Tumor TherapeuticsGoogle:
"joseph moskal"Mean distance: 106866
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Burgdorf J, Brudzynski S, Moskal J. (2020) Using rat ultrasonic vocalization to study the neurobiology of emotion: from basic science to the development of novel therapeutics for affective disorders. Current Opinion in Neurobiology. 60: 192-200 |
Burgdorf JS, Christian EP, Sørensen L, et al. (2019) A translational EEG-based approach to assess modulation of long-lasting NMDAR-dependent synaptic plasticity. Psychopharmacology |
Bowers MS, Cacheaux LP, Sahu SU, et al. (2019) NYX-2925 induces metabotropic NMDAR signaling that enhances synaptic NMDAR and AMPAR. Journal of Neurochemistry |
Donello JE, Banerjee P, Li YX, et al. (2018) Positive N-Methyl-D-Aspartate Receptor Modulation by Rapastinel Promotes Rapid and Sustained Antidepressant-like Effects. The International Journal of Neuropsychopharmacology |
Ghoreishi-Haack N, Priebe JM, Aguado JD, et al. (2018) NYX-2925 is a novel NNMDA receptor modulator that induces rapid and long-lasting analgesia in rat models of neuropathic pain. The Journal of Pharmacology and Experimental Therapeutics |
Khan MA, Houck DR, Gross AL, et al. (2017) NYX-2925 is a novel NMDA receptor-specific spirocyclic-β-lactam that modulates synaptic plasticity processes associated with learning and memory. The International Journal of Neuropsychopharmacology |
Liu RJ, Duman C, Kato T, et al. (2016) GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |
Moskal JR, Burgdorf JS, Stanton PK, et al. (2016) The Development of Rapastinel (Formerly GLYX-13); a rapid acting and long lasting antidepressant. Current Neuropharmacology |
Burgdorf J, Zhang XL, Weiss C, et al. (2015) The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus. Neuroscience. 308: 202-211 |
Zhang XL, Shuttleworth CW, Moskal JR, et al. (2015) Suppression of spreading depolarization and stabilization of dendritic spines by GLYX-13, an NMDA receptor glycine-site functional partial agonist. Experimental Neurology. 273: 312-321 |